Ultragenyx Pharmaceutical (RARE) FCF Margin (2016 - 2026)
Ultragenyx Pharmaceutical's FCF Margin was -45.79% in Q2 2026, up 21.27 percentage points from -67.07% a year earlier and up 99.79 percentage points from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) FCF Margin (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ultragenyx Pharmaceutical's FCF Margin was -68.18% through Jun 30, 2026, up 1.82 percentage points year-over-year; for FY2025, it was -70.13%, up 5.04 percentage points from FY2024.
- FCF Margin has now increased for three consecutive years, though with a five-year change of -5.15 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -75.18% in FY2024 (+44.41 pp), -119.59% in FY2023 (+17.09 pp), -136.68% in FY2022 (-19.49 pp) and -117.18% in FY2021 (-52.20 pp).
- The Q2 2026 figure marks the highest quarterly FCF Margin since Q2 2020.
- Compared with a year earlier, FCF Margin was higher in four of the last eight quarters, with an average year-over-year change of +15.68 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q3 2024 (a gain of 74.80 percentage points); the worst was Q3 2022 (a drop of 35.59 percentage points).
- Per Business Quant data, RARE's FCF Margin in the three quarters before Q2 2026 was -145.59% (Q1 2026), -48.61% (Q4 2025) and -57.67% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn | -45.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -45.79% |
| Mar 31, 2026 | -145.59% |
| Dec 31, 2025 | -48.61% |
| Sep 30, 2025 | -57.67% |
| Jun 30, 2025 | -67.07% |
| Mar 31, 2025 | -120.14% |
| Dec 31, 2024 | -48.27% |
| Sep 30, 2024 | -49.19% |
| Jun 30, 2024 | -53.71% |
| Mar 31, 2024 | -178.20% |
| Dec 31, 2023 | -67.19% |
| Sep 30, 2023 | -123.98% |
| Jun 30, 2023 | -120.12% |
| Mar 31, 2023 | -181.00% |
| Dec 31, 2022 | -113.51% |
| Sep 30, 2022 | -133.83% |
| Jun 30, 2022 | -121.08% |
| Mar 31, 2022 | -187.28% |
| Dec 31, 2021 | -84.41% |
| Sep 30, 2021 | -98.24% |
API Access
Ultragenyx Pharmaceutical FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();